Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date High-Resolution Optical and Dielectric Methods Monitoring Cells in Bioprocesses Michael Butler, PhD, Professor and Principal Investigator, National Institute for Bioprocessing Research and Training (NIBRT) Presented by Michael Butler, PhD, Professor and Principal Investigator, National Institute for Bioprocessing Research and Training (NIBRT) The metabo... 2 years ago | 76 mins Fast-tracking C010DS-Zn: PARP1-agonist targeting cancer and M2-like macrophages Jinhyuk Fred Chung, PhD, Chief Scientific Officer, Xylonix Pte. Ltd. Parthanatos (a programmed necrosis from PARP1 hyperactivation) is an untapped death mechanism in oncology, and it offers some ideal features for cance... 3 years ago | 40 mins Factors to Consider When Choosing Cell-based Assays for Use with 3D Cultures Terry Riss, Ph.D. Join us for a special Corning sponsored webinar presented by Promega Corporation. Cells cultured in 3D model systems often acquire relatively large i... 8 years ago | 60 mins Ask the Experts: 3D Cell Culture and Assays Terry Riss, Ph.D. and Austin Mogen, Ph.D. 3D culture experts from Corning and Promega answer questions about common methods to form 3D structures, and factors to consider when evaluating cell-... 3 years ago | 70 mins Selective Ablation of Malignant Cells using Apoptotic Gene Therapy Jailal Ablack, PhD, Head of Preclinical Research, OncoSenX While chemotherapy is a key treatment strategy for many solid tumors, it is rarely selective for tumor cells. OncoSenx has developed an effective suic... 3 years ago | 34 mins Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck SCCs Francis Burrows, PhD, VP of Translational Research, Kura Oncology Tipifarnib is a potent and highly selective inhibitor of farnesyltransferase (FT). FT catalyzes the post-translational attachment of farnesyl grou... 3 years ago | 43 mins
